Stocktoria

Lifevantage Corp LFVN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-09-12 · LEI

Lifevantage Corp financials (annual)

Revenue
$199.5M $203.2M $226.0M $232.9M $220.2M $206.4M $213.4M $200.2M $228.5M $182.6M 2017201820192020202120222023202420252026
Net income
$1.6M $5.8M $7.4M $11.5M $12.9M $3.1M $2.5M $2.9M $9.8M $5.1M 2017201820192020202120222023202420252026
Free cash flow
$5.5M $8.6M $15.3M $15.6M $12.5M $6.4M $3.8M $10.0M $10.5M $6.7M 2017201820192020202120222023202420252026

Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$182.6M$228.5M$200.2M$213.4M$206.4M$220.2M$232.9M$226.0M$203.2M$199.5M
Gross profit$141.6M$183.7M$158.7M$170.0M$168.3M$182.0M$195.0M$188.0M$168.4M$166.0M
R&D expense$1.0M$1.4M$700,000$600,000$700,000$700,000$900,000$1.1M$1.2M$1.1M
SG&A expense$58.4M$69.2M$68.5M$71.1M$63.4M$60.8M$67.9M$69.6M$59.8M$64.9M
Operating income$6.1M$12.2M$4.3M$4.3M$7.6M$17.6M$15.5M$9.8M$10.3M$4.4M
Interest expense——-$430,000-$198,000$10,000$17,000$120,000$323,000$456,000$570,000
Income tax$994,000$2.4M$1.4M$1.5M$1.6M$4.3M$3.1M$1.8M$3.8M$1.3M
Net income$5.1M$9.8M$2.9M$2.5M$3.1M$12.9M$11.5M$7.4M$5.8M$1.6M
EPS (diluted)$0.40$0.75$0.23$0.20$0.24$0.90$0.79$0.50$0.41$0.11
Operating cash flow$10.2M$11.9M$12.2M$6.8M$8.0M$16.3M$18.3M$17.8M$13.3M$6.6M
Free cash flow$6.7M$10.5M$10.0M$3.8M$6.4M$12.5M$15.6M$15.3M$8.6M$5.5M
Cash & equivalents—$20.2M$16.9M$21.6M$20.2M$23.2M$22.1M$18.8M$16.7M$11.5M
Inventory$16.2M$20.7M$15.1M$16.1M$16.5M$16.1M$13.9M$13.8M$13.6M$16.6M
Total assets$62.1M$72.0M$60.3M$66.1M$70.7M$78.7M$58.9M$55.3M$51.1M$45.2M
Total liabilities$28.5M$37.3M$34.3M$31.5M$39.2M$41.9M$25.6M$28.1M$29.2M$30.7M
Shareholders' equity$33.6M$34.6M$26.0M$34.6M$31.5M$36.8M$33.3M$27.2M$21.9M$14.5M

Growth · year-over-year · Revenue CAGR -1%

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth-20.1%+14.2%-6.2%+3.4%-6.3%-5.5%+3.1%+11.2%+1.9%-3.4%
Net income growth-48.3%+233.8%+15.6%-18.6%-75.8%+11.6%+55.5%+29.0%+258.3%-73.7%
EPS growth-46.7%+226.1%+15.0%-16.7%-73.3%+13.9%+58.0%+22.0%+272.7%-73.8%
Free cash flow growth-36.5%+5.6%+164.6%-41.5%-48.7%-19.9%+2.4%+77.6%+55.3%+1.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.